Form 4: Cargo Therapeutics CFO Anup Radhakrishnan Reports Acquisition and Disposal of Common Stock
SEC Filing
Anup Radhakrishnan, CFO and COO of Cargo Therapeutics, reports acquiring and disposing of common stock and restricted stock units.
Summary
- Anup Radhakrishnan, the Chief Financial Officer and Chief Operating Officer of Cargo Therapeutics, Inc., filed a Form 4.
- The report details changes in beneficial ownership of the company's securities.
- On March 14, 2025, Radhakrishnan acquired 72,500 shares of common stock and disposed of 78,946 shares.
- The acquisition was related to restricted stock units (RSUs) vesting, where each RSU entitles the holder to one share of common stock.
- 1/16th of the RSUs vest on each quarterly anniversary measured from January 1, 2025, with full vesting occurring on the fourth anniversary.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice for company insiders to report transactions in their company's stock, ensuring transparency and compliance with securities regulations.
Key Dates
| Date | Description |
|---|---|
| January 1, 2025 | Vesting Commencement Date for RSUs |
| March 14, 2025 | Date of transaction: acquisition and disposal of common stock |
| March 18, 2025 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.